Similar articles

• Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).

  Kalra S, Vithalani M, Gulati G, Kulkarni CM, Kadam Y, Pallivathukkal J, Das B, Sahay R, Modi KD. Kalra S, et al. J Assoc Physicians India. 2013 Jul;61(7):448-53. J Assoc Physicians India. 2013. PMID: 24772746
• Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.

  Zhang LY, Jin YJ, Jin QS, Lin LY, Zhang DD, Kong LL. Zhang LY, et al. Gene. 2013 Oct 25;529(2):340-4. doi: 10.1016/j.gene.2013.08.001. Epub 2013 Aug 14. Gene. 2013. PMID: 23954219
• Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.

  Williams KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM. Williams KH, et al. Endocr Rev. 2013 Feb;34(1):84-129. doi: 10.1210/er.2012-1009. Epub 2012 Dec 13. Endocr Rev. 2013. PMID: 23238855 Review.
• [Pathogenetic substantiation of complex treatment of nonalcoholic steatohepatitis and steatosis in patients with pre-diabetes and type 2 diabetes].

  Чопей ІВ, Івачевська ВВ, Чубірко КІ, Гряділь ТІ, Гечко ММ. Чопей ІВ, et al. Wiad Lek. 2017;70(2):169-173. Wiad Lek. 2017. PMID: 28511152 Ukrainian.
• Nonalcoholic Fatty Liver Disease: The New Complication of Type 2 Diabetes Mellitus.

  Bril F, Cusi K. Bril F, et al. Endocrinol Metab Clin North Am. 2016 Dec;45(4):765-781. doi: 10.1016/j.ecl.2016.06.005. Epub 2016 Oct 4. Endocrinol Metab Clin North Am. 2016. PMID: 27823604 Review.